Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ekos introduces new endovascular system
According to the company, the EkoSonic ES design features include an advanced control unit with an easier, more intuitive user interface, making set up and operation simple. EkoSonic
According to the company, the EkoSonic ES design features include an advanced control unit with an easier, more intuitive user interface, making set up and operation simple. EkoSonic
The company said that the underwriters of the offering have exercised their over-allotment option and purchased 525,000 additional shares of common stock from the selling stockholders at the
The recombinant botulinum (rBOT) vaccine grant is for the continued development, over a three-year period, of a serotype A and B recombinant botulinum vaccine. This is the first
The future payments will be tied to revenues of the business in the two years after closing. The acquisition is expected to be completed in the third calendar
Health Canada’s decision is said to be the first marketing authorization worldwide for any Friedreich’s Ataxia therapy. The new drug will be marketed in Canada under the brand
The company has acquired Parkway for an aggregate purchase price of $2.9 million, consisting of $1.9 million in cash and $1 million of Rosetta’s ordinary shares. An additional
These findings resulted from supportive statistical analyses based on data from the pivotal Phase III clinical trial of Advexin in patients with recurrent, refractory head and neck cancer.
The Phase I trial was designed to evaluate safety, distribution and dosimetry of BFPET in 12 healthy subjects following a single dose injection at rest. BFPET is FluoroPharma’s
Worldwide net revenue increased 5% to $5.9 billion for the 2008 second quarter and 6% to $11.7 billion for the 2008 first half. Excluding the favorable impact of
The company reported diluted EPS of $0.41 in the second quarter of 2008, an increase of 128% compared with $0.18 in the prior-year quarter. Total revenues for the